Healthcare Professionals
Adapta
Pacing System for Bradyarrhythmia Management
With MVP To Pace Less
The Adapta™ pacemaker models combine physiologic pacing with automaticity. Adapta DR is the first pacemaker with Managed Ventricular Pacing (MVP™) technology, which reduces unnecessary right ventricular pacing by 99%.1 Reducing unnecessary ventricular pacing has been shown to improve clinical outcomes by reducing the risks of atrial fibrillation (AF)2-5 and heart failure hospitalization (HFH).2,5
Model Specifications
| Device | Model Number | Asset |
|---|---|---|
|
Adapta DR |
ADDR01 |
Not available |
|
Adapta DR |
ADDR03 |
Not available |
|
Adapta DR |
ADDR06 |
Not available |
|
Adapta DR |
ADDRS1 (small) |
Not available |
|
Adapta DR |
ADDRL1 (longevity) |
Not available |
|
Adapta D |
ADD01 |
Not available |
|
Adapta VDD |
ADVDD01 |
Not available |
|
Adapta SR |
ADSR01 |
Not available |
|
Adapta SR |
ADSR03 |
Not available |
|
Adapta SR |
ADSR06 |
Not available |
1
Gillis A, Pürerfellner H, Israel C, et al. Reduction of unnecessary ventricular pacing due to the Managed Ventricular Pacing (MVP) mode in pacemaker patients: Benefit for both sinus node disease (SND) and AV block (AVB) indications. Presented at HRS 2005 (Abstract AB21-1).
2
Anderson HR, et al. Lancet. 1997;350:1210-1216.
3
Skanes AC, et al. J Am Coll Cardiol. 2001;38:167-172.
4
Neilsen J, et al. J Am Coll Cardiol. 2003;42:614-623.
5
Sweeney M, et al. Circulation. 2003;107:2932-2937.